BRCA1

(redirected from Genes, brca1)
Also found in: Dictionary, Wikipedia.
Related to Genes, brca1: BRCA2 gene

BRCA1

symbol for a breast cancer gene. BRCA1 is a tumor suppressor gene. A healthy BRCA1 gene produces a protein that protects against unwanted cell growth. The protein is packaged by the cell's Golgi apparatus into secretory vesicles, which release their contents on the cell's surface. The protein circulates in the intracellular space, attaching itself to neighboring cell receptors. The receptors signal the cell nuclei to stop growing. When the gene is defective, it produces a faulty protein that is unable to prevent proliferation of abnormal cells as they evolve into potentially deadly breast cancer. BRCA1 may also normally inhibit ovarian cancer.

BRCA1

A gene on chromosome 17q21, which encodes a protein that plays a role in maintaining genomic stability and acts as a tumour suppressor. It combines with other tumour suppressors, DNA damage sensors and signal transducers to form a large multi-subunit-protein complex known as the BRCA1-associated genome surveillance complex (BASC), which associates with RNA polymerase II and histone deacetylase complexes, thus playing a role in transcription, DNA repair of double-stranded breaks and recombination. BRCA1 mutations cause 40% of inherited breast cancers and over 80% of inherited breast and ovarian cancers.

BRCA1

Molecular oncology A large tumor suppressor gene on chromosome 17 which is linked to breast, ovarian, prostate and other CAs; Pts with BRCA1 represent 5% of all breast CAs; ♀ with BRCA1 have an 85% chance of developing breast CA before age 65; mutations of BRCA1 are common in Ashkenazi Jews Lab BRCA1 and BRCA2 are part of some commercial diagnostic labs' genetic services. See Tumor suppressor gene.
References in periodicals archive ?
Also, because the study began before the discovery that alterations in two genes, BRCA1 and 2, may predispose a woman to breast cancer, the trial could not determine whether tamoxifen had unusual benefit for women carrying the genes.
7] One of these genes, BRCA1, was identified in 1994 and is thought to be a tumor suppressor gene that codes for a protein capable of negatively regulating tumor growth.
Current tests for this disease examine two genes, BRCA1 and BRCA2, which account for only five percent of the inherited risk for early-onset breast cancer.
Scientists at the University of Nottingham focused on inherited cancer causing genes, BRCA1 and BRCA2, as they cause up to 10 percent of breast cancers that are more often fatal than non-genetic tumours.
The study found that a chemical called indol-3-carbonol (I3C) which occurs naturally in cruciferous vegetables like broccoli, cauliflower, cabbage, and sauerkraut, boosts the activity of two genes, BRCA1 and BRCA2, which then work to detect and repair damaged DNA.
Two previously identified genes, BRCA1 and BRCA2, are linked to an inherited form of breast cancer, which accounts for 5 to 10 percent of cases.
The study, involving 979 men with prostate cancer and 1251 men without the disease, looked at whether participants carried mutations for either of two genes, BRCA1 and BRCA2.
The well known breast cancer genes, BRCA1 and BRCA2, account for only 5% of breast cancers in white women.
It is only in the past 10 years that scientists have identified faults on two genes, BRCA1 and BRCA2, that are linked to breast and ovarian cancer.
At least one in 200 women have an inherited mutation in one of two genes, BRCA1 and BRCA2, which both increase chances of breast cancer.
Positional cloning is a highly productive method of finding disease genes, responsible for more human disease-related gene discoveries than any other method, and includes discovery of the breast and ovarian cancer susceptibility genes, BRCA1 and BRCA2, the AGT salt-sensitive hypertension gene and the melanoma susceptibility gene, MTS1.
The two genes, BRCA1 and BRCA2, code for proteins with novel tumor suppressor functions.